The oncology clinical development playing field is competitive and always changing. Our oncology product platform enables you to set up a trial with a single, dedicated team. Our group has the therapeutic expertise and relationships with key opinion leaders in the field to advise you through the full product development spectrum — from early Phase I through global Phase III.
Whether you are developing specialized products or working through a complex trial, our team can help you through new, unusual and difficult designs.
In the last five years, Chiltern has conducted 518 oncology clinical trials.
Oncology Product Platform
Investigators
Patients
Countries
Total Studies
